Conditions: Non-Small-Cell Lung Carcinoma
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 106
Healthy volunteers: no

Brief summary:
This is a study of E7389 in patients with recurrent and/or metastatic Non-Small-Cell Lung Cancer (NSCLC) who progressed during or after treatment with a platinum agent and another chemotherapy.

Detailed description:

Arms:
arm 1: E7389 28 day cycle arm 2: E7389 21 day cycle

Interventions: intervention 1: E7389 28 Day Cycle intervention 2: E7389 21 Day Cycle
Intervention descriptions: intervention 1: E7389 1.4 mg/m\^2 IV bolus on Days 1, 8, and 15 of a 28 day cycle. intervention 2: E7389 1.4 mg/m\^2 IV bolus on Days 1 and 8 of a 21 day cycle.

Protocol document: